NIGHTINGALE HEALTH EO 1
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blo… Read more
NIGHTINGALE HEALTH EO 1 (7XE) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, NIGHTINGALE HEALTH EO 1 (7XE) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
NIGHTINGALE HEALTH EO 1 - Net Assets Trend (None–None)
This chart illustrates how NIGHTINGALE HEALTH EO 1's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NIGHTINGALE HEALTH EO 1 (None–None)
The table below shows the annual net assets of NIGHTINGALE HEALTH EO 1 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to NIGHTINGALE HEALTH EO 1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
NIGHTINGALE HEALTH EO 1 Competitors by Market Cap
The table below lists competitors of NIGHTINGALE HEALTH EO 1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Loncor Gold Inc
OTCQX:LONCF
|
$46.34 Million |
|
Nusatrip Incorporated Common Stock
NASDAQ:NUTR
|
$46.35 Million |
|
SPECTRUM
NSE:SPECTRUM
|
$46.35 Million |
|
Magnitude International Ltd Ordinary Shares
NASDAQ:MAGH
|
$46.36 Million |
|
GUMI INC.
F:1G9
|
$46.34 Million |
|
Horizon Space Acquisition II Corp. Ordinary share
NASDAQ:HSPT
|
$46.31 Million |
|
Windsor Machines Limited
NSE:WINDMACHIN
|
$46.31 Million |
|
Airnet Technology Inc
NASDAQ:ANTE
|
$46.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NIGHTINGALE HEALTH EO 1's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares NIGHTINGALE HEALTH EO 1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently NIGHTINGALE HEALTH EO 1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares NIGHTINGALE HEALTH EO 1's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NIGHTINGALE HEALTH EO 1 (7XE) | €- | N/A | N/A | $46.34 Million |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |